TY  - GEN
AU  - Penka,M
AU  - Schwarz,J
AU  - Pavlík,T
AU  - Pytiĺk,R
AU  - Doubek,M
AU  - Dulícek,P
AU  - Kissová,J
AU  - Hlusi,A
AU  - Schutzová,M
AU  - Cerná,O
AU  - Brychtová,Y
AU  - Szotkowski,T
AU  - Volková,Z
AU  - Seghetová,J
AU  - Vozobulová,V
AU  - Hadacová,I
AU  - Hochová,I
AU  - Voglová,J
AU  - Dusek,L
TI  - [What is the current treatment of patients with essential thrombocytopenia and other myeloproliferations accompanied with thrombocythemia [corrected] and what can be the predictive sign of the risk of thrombosis in such patients--a report from the registry of patients treated by Thromboreductine]
SN  - 0042-773X
PY  - 2008///1002
KW  - Female
KW  - Fibrinolytic Agents
KW  - adverse effects
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Myeloproliferative Disorders
KW  - blood
KW  - Platelet Aggregation Inhibitors
KW  - Platelet Count
KW  - Quinazolines
KW  - Risk Assessment
KW  - Thrombocythemia, Essential
KW  - Thrombocytopenia
KW  - complications
KW  - Thrombosis
KW  - etiology
N1  - Publication Type: Journal Article
ER  -